A case report highlights cutaneous leukocytoclastic vasculitis as a rare adverse event associated with infliximab treatment in Crohn's disease. This finding underscores the need for vigilance in monitoring adverse effects in patients receiving this therapy.
cutaneous leukocytoclastic vasculitis as a rare adverse event of infliximab in crohn s disease a case report
Original title: “Cutaneous Leukocytoclastic Vasculitis as a rare adverse event of infliximab in Crohn's disease: a case report.”